Investors had a mixed reaction to Fresenius’ half-year results, which saw the firm perform poorly on a group-level, but the core businesses highlighted by the restructuring plan perform well. The company did not confirm rumours of divestments.
Ophthalmology continues to be a big area of interest for investors, with considerable scope for consolidation. An expert panel including the CEO of Europe's largest chain (Veonet) and the CEO of Latin America's largest player (Opty) discussed opportunities in the sector at HBI 2023.
Germany-based healthcare conglomerate Fresenius’ restructuring plans seem to be gathering steam, as HBI hears the sale of its Spain-based fertility clinic Eugin is imminent.
Emerging markets present opportunities you wouldn't find in more established geographies. In a panel entitled ‘investing in emerging markets’ at HBI 2023 in London, panellists explored where the most potential for investment in emerging markets lies. The main takeaways were:
As public health experts, governments, and the WHO ask questions about the risks posed by AI, HBI speaks to two market experts. Should we be concerned or optimistic about its increasing use, specifically in health care?
Ahead of HBI 2023 next month, we catch up with dentistry panelist Rahma Samow, EVP dental services organizations at Straumann Group, to find out more about her role and the trends surrounding oral health and their impact on enterprise DSOs globally.
Western Europe is becoming increasingly dependent on importing talent to address its workforce crisis, but there are signs of resistance to the brain drain. With Nigeria looking to introduce a mandatory domestic five-year service for all doctors, HBI speaks to a global workforce expert to see if this kind of pushback could have any lasting impact.
Last month, thought leaders from private healthcare systems across the globe gathered in Cape Town, South Africa, to network, share their findings, and consider how emerging markets can become more resilient. HBI was there, and these are our key themes and takeaways.
HBI caught up with Norberto Jannuzzi, partner at Brazil based private equity group Patria Investimentos and 'Making smart investment choices' panelist at IFC’s Global Private Health Conference in Cape Town this week.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy